For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real-world efficacy.
The shift could cut off tens of thousands of people from treatment.
Harerimana Ismail of Uganda is a community health worker who checks on kids with HIV. He lost his salary after the Trump ...
The world may look back on 2024 as a pivotal time in the fight against AIDS — the start of a revolution in the global biomedical response to HIV using long-acting antiretroviral medicines. Young women ...
Thousands of low-income Americans with HIV are losing access to vital medications, as states grapple with a lack of federal ...
For years, the Branch House Family Justice Center has continually grown to offer the best care to survivors of abuse.
Zambia has received more than $6 billion in HIV/AIDS over the last two decades, according to the US Embassy in Zambia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results